Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 314 | 432 | 553 | 634 | 1,673 |
| Cost of Goods | 261 | 155 | 180 | 232 | 320 |
| Gross Profit | 53 | 277 | 373 | 402 | 1,353 |
| Operating Expenses | 4,367 | 3,620 | 3,235 | 3,245 | 3,537 |
| Operating Income | -4,053 | -3,189 | -2,682 | -2,611 | -1,864 |
| Interest Expense | 0 | 29 | 29 | 29 | 0 |
| Other Income | -73 | -73 | -240 | -22 | 645 |
| Pre-tax Income | -4,125 | -3,290 | -2,951 | -2,663 | -1,219 |
| Net Income Continuous | -4,125 | -3,290 | -2,951 | -2,663 | -1,234 |
| Minority Interests | 0 | -1 | -1 | 0 | N/A |
| Net Income | $-4,125 | $-3,290 | $-2,950 | $-2,663 | $-1,224 |
| EPS Basic Total Ops | -13.80 | -14.40 | -15.80 | -22.40 | -13.40 |
| EPS Basic Continuous Ops | -14.05 | -14.37 | -15.70 | -22.37 | -7.03 |
| EPS Diluted Total Ops | -13.80 | -14.40 | -15.80 | -22.40 | -13.40 |
| EPS Diluted Continuous Ops | -14.05 | -14.37 | -15.70 | -22.37 | -7.03 |
| EBITDA(a) | $-3,964 | $-3,120 | $-2,609 | $-2,530 | $-1,784 |